Recombinant EGFR (Zalutumumab Biosimilar) 抗体
This anti-EGFR (Zalutumumab Biosimilar) antibody is a Mammalian Cells 单克隆 antibody detecting EGFR (Zalutumumab Biosimilar) in ELISA. Suitable for 人.
Quick Overview for Recombinant EGFR (Zalutumumab Biosimilar) 抗体 (ABIN7487875)
抗原
EGFR (Zalutumumab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Mammalian Cells
克隆类型
单克隆
标记
This EGFR (Zalutumumab Biosimilar) antibody is un-conjugated
应用范围
ELISA
质量等级
Research Grade
-
-
Expression System
- Mammalian cells
-
原理
- Zalutumumab Biosimilar - Anti-EGFR mAb
-
产品特性
- Antibody Type: IgG1-kappa
-
纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
-
亚型
- IgG1 kappa
-
-
-
-
限制
- 仅限研究用
-
-
-
缓冲液
- PBS pH 7.5
-
储存条件
- -80 °C
-
储存方法
- store at -80°C
-
-
- EGFR (Zalutumumab Biosimilar)
-
物质类
- Biosimilar
-
背景
-
HuMax-EGFr
Zalutumumab (proposed trade name HuMax-EGFR) is a high affinity, completely human IgG1 monoclonal antibody (mAb) directed towards the epidermal growth factor receptor (EGFR, also known as ErbB1/HER1). It is developed by Genmab and designed for the treatment of squamous cell carcinoma of the head and neck (SCCHN), a type of cancer. Zalutumumab is derived from transgenic mice immunized with A431-derived EGFR. -
CAS-编号
- 667901-13-5
抗原
-
You are here:
